BibTex RIS Kaynak Göster

ORAL HEALTH CARE IN PATIENTS UNDERWENT CHEMOTHERAPY AND RADIOTHERAPY

Yıl 2006, Cilt: 2006 Sayı: 3, 50 - 55, 01.03.2006

Yrd. Doç. Dr. Binali Çakur Araş. Gör. Dt. Özkan Miloğlu Prof. Dr. Abubekir Harorlı

https://izlik.org/JA82YY65MG

Öz

-

Anahtar Kelimeler

-

Kaynakça

  • Shaw M.J, Kumar N.D.K, Duggal M, Fiske J, Lewis D.A, Kinsella T, Nisbet T. Oral management of patients following oncology treatment: literaturereview. British Journal Of Oral&Maxillofacial Surgery 2000; 38: 519 - 524
  • Scully C, Epstein J.B. Oral Health Care for the Cancer Patient: Reviews. Oral Oncol, Eur J Cancer 1996; 32B: 281 – 92
  • Joyston-Bechal S, Hayes K, Davenport ES, Hardie JM. Caries incidence, mutans streptococci and lactobacilli in irradiated patients during a 12 month preventive programme using chlorhexidine and fluoride. Caries Res 1992; 26: 384–390
  • Lockhart PB, Clarke J. Pre-therapy dental status of patients with malignant conditions of the head and neck. Oral Surg Oral Med Oral Pathol 1994; 77: 236–241
  • Epstein JB, McBride GC, Stevenson-Moore P, Merilees H, Spinelli J. The efficacy of chlorhexidine gel in reduction of Streptococcus mutans and Lactobacillus species in patients treated with radiation therapy. Oral Surg Oral Med Oral Pathol 1991; 71: 172–178
  • Harorl A, Ylmaz A.B, Akgul H.M. Rayolojide Temel Kavramlar ve Radyodiagnostik. Erzurum: Ata. Uni. Ziraat Fak. Ofset Tesisleri, 2001; 45–55 7. Çankaya H. Kemoterapi Sonucu Gözlenen Oral De8iiklikler ve Tedavi Yaklamlar. E. Ü. Di Hek. Fak. Derg. 2001; 22: 103–108
  • Barker G, Loftus L, Cuddy P, Baker B. The effects of sucralfate suspension on radiotherapy induced mucositis. Oral Surg Oral Med Oral Pathol 1991; 71: 288–293
  • Franzen L, Henriksson R, Littbrand B, Zackrisson B. Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebocontrolled study.Acta Oncol 1995; 34: 219-223
  • Spijkervet FKL, Saene HKF van, Panders AK et al. Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis. Oral Surg Oral Med Oral Pathol 1989; 67: 154- 161.
  • Epstein JB, Stevenson-Moore P. Benzydamine hydrochloride in prevention and management of pain in oral mucositis associated with radiation therapy. Int J Radiat Oncol Bio Phys 1986; 62: 145–148
  • Wadleigh RG, Redman RS, Graham ML. Vitamin E in the treatment of chemotherapy-induced mucositis. Am J.Med 1992; 92: 481-484.
  • Ciasis G, Namer M, Schneider M. Laser therapy in the prevention and treatment of mucositis caused by anticancer chemotherapy. Bull Cancer Paris 1992; 79: 183–191
  • Joseph A. Regezi, James J. Scubba, Richard C.K. Jordan. Oral Pathology. Saunders. USA 2003:7679
  • Thomas CJ, Nutt GM. The in vitro fungicidal properties of Viscogel alone and combined with Nystatin and Amphotericin B. Oral Rehab 1978; 5:167–172
  • Meunier F, Paesmans M, Autier P. Value of antifungal prophylaxis with antifungal drugs againist oropharyngeal candidiasis in cancer patients. Oral Oncol,Eur J Cancer 30B,196-199
  • Barkvoll P, Attramadal A. Effect of nystatin and chlorhexidine digluconate on Candida albicans. Oral Surg Oral Med Oral Pathol 1989;67:279-281
  • Stephen LC, Schulthesiss TE, Price RE, Ang KK, Peters LI. Radiation apoptosis of serous acinar cells of salivary and lacrimal glands.Cancer 1991; 67: 1539-1543
  • Mira JG, Fullerton GD, Wescott WB. Correlation between initial salivary flow rate and radiation dose in the production of xerostomia.Acta Radiol Oncol 1982; 21: 151-154
  • Shum CA, Izutsu KT, Molbo DM et al. Changes in salivary buffer capacity in patients undergoing cancer chemotherapy.J Oral Med 1979; 34: 76-80
  • Robert A.O, Blanchaert R. Current management of oral cancer: A multidisciplinary approach. JADA 2001; 32:19 -23
  • Herod EL. The use of milk as a saliva substitute. J Public Health Dent 1994;54:184-189
  • Risheim H, Amegerg P. Salivary stimulation by chewing gum and lozenges in rheumatic patients with xerostomia.Scand J Dent Res 1993;101:4043
  • Fox PC, Atkinson JC, Macynski AA et al. Pilocarpine treatment of salivary gland hypofunction and dry mouth(xerostomia). Arch Intern Med 1991;151: 1149–1152
  • Epstein JB, Burchill JL, Emerton S, Le N,Silverman S Jr. A clinical trial of bethanechol in patients with xerostomia after radiation therapy a pilot study. Oral Surg Oral Med Oral Pathol 1994; 77: 610– 614
  • Epstein J, Stevenson-Moore P.A. Clinical comparative trial of saliva substitutes in radiationinduced salivary gland hypofunction.Spec Care Dent 1992;12: 21-23
  • Visch LL, S’Gravenmade EJ; Schraub RM et al. A double blind crossover trial of CMC- and mucincontaining saliva substitutes. Int J Oral Maxillofac Surg 1986; 15: 395–400
  • Epstein JB, Schubert MM. Management of orofacial pain in cancer patients.Oral Oncol,Eur J Cancer 1993; 29B: 243-250
  • Berger A, Henderson M, Nadoolman W et al. Oral capsaicin provides temporary relief for oral mucositic pain secondary to chemotherapy/ radiation therapy. J Pain Symptom Manag 1995;10: 243–248
  • Mossman KL, Henkin RI Radiation-induced changes in taste acuity in cancer patients. Int J Radiat Oncol Phys 1978; 4: 663–670
  • Brunello DL, Mandikos MN. The use of a dynamic opening device in the treatment of radiation induced trismus.Aust Prosthodont J 1995; 9: 4548
  • Lockhart PB, Clark J. Pretherapy dental status of patients with malignant conditions of the head and neck. Oral Surg 1994; 77: 236–241
  • Feber T. Mouth care for patients receiving oral irradiation. Professional Nurse 1995;10: 666–670
  • Scully C, Flint S, Porter SR. Oral diseases. London: Martin Dunitz, 1996; 198.
  • Kluth EV, Jain PR, Struhell RN, Frich JC. A study of factors contributing to development of osteoradionecrosis of the jaws. J Prosth Dent 1988; 59: 194–201
  • McKenize MR, Wong FLW, Epstein JB, Lepawsky M. Hyperbaric oxygen and postradiation osteonecrosis of the mandible. Oral Oncol,Eur J Cancer 1993; 29B: 201-207
  • King GE, Scheetz J,Jacob RF et al. Electrotherapy and hyperbaric oxygen:promising treatments for post-radiation complications. J Prosthet Dent 1989; 62: 331–334
  • Harris M. The conservative management of osteoradionecrosis of the mandible with ultrasound therapy. Br J Oral Maxillofac Surg 1992; 30: 313–318
  • Reher P, Doan N, Bradnock B, Meghji S, Haris M. Therapeutic ultrasound for osteoradionecrosis: an in vitro comparison between 1 MHz and 45 kHz machines. Eur J Cancer 1998; 34: 1962–1968

RADYOTERAPİ VE KEMOTERAPİ GÖREN HASTALARDA ORAL BAKIM

Yıl 2006, Cilt: 2006 Sayı: 3, 50 - 55, 01.03.2006

Yrd. Doç. Dr. Binali Çakur Araş. Gör. Dt. Özkan Miloğlu Prof. Dr. Abubekir Harorlı

https://izlik.org/JA82YY65MG

Öz

Malign hastal klar n tedavisinde kemoterapi ve radyoterapi yayg n olarak kullan l r. Bu tedavilerin amac h zla ço8alabilen neoplazik hücreyi ortadan kald rmakt r. Ancak bu tedavi ekilleri oral mukoza dokular n , tükürük bezlerini, orofasiyal kan damarlar nve kemik ili8ini hasara u8ratabilir. Orofasiyal komplikasyonlar; kemoterapi sonras ve ba boyun radyoterapisini takiben yayg n olarak kar m za ç kar. Bu makale de radyoterapi ve kemoterapi

Anahtar Kelimeler

Kanser Kemoterapi

Kaynakça

  • Shaw M.J, Kumar N.D.K, Duggal M, Fiske J, Lewis D.A, Kinsella T, Nisbet T. Oral management of patients following oncology treatment: literaturereview. British Journal Of Oral&Maxillofacial Surgery 2000; 38: 519 - 524
  • Scully C, Epstein J.B. Oral Health Care for the Cancer Patient: Reviews. Oral Oncol, Eur J Cancer 1996; 32B: 281 – 92
  • Joyston-Bechal S, Hayes K, Davenport ES, Hardie JM. Caries incidence, mutans streptococci and lactobacilli in irradiated patients during a 12 month preventive programme using chlorhexidine and fluoride. Caries Res 1992; 26: 384–390
  • Lockhart PB, Clarke J. Pre-therapy dental status of patients with malignant conditions of the head and neck. Oral Surg Oral Med Oral Pathol 1994; 77: 236–241
  • Epstein JB, McBride GC, Stevenson-Moore P, Merilees H, Spinelli J. The efficacy of chlorhexidine gel in reduction of Streptococcus mutans and Lactobacillus species in patients treated with radiation therapy. Oral Surg Oral Med Oral Pathol 1991; 71: 172–178
  • Harorl A, Ylmaz A.B, Akgul H.M. Rayolojide Temel Kavramlar ve Radyodiagnostik. Erzurum: Ata. Uni. Ziraat Fak. Ofset Tesisleri, 2001; 45–55 7. Çankaya H. Kemoterapi Sonucu Gözlenen Oral De8iiklikler ve Tedavi Yaklamlar. E. Ü. Di Hek. Fak. Derg. 2001; 22: 103–108
  • Barker G, Loftus L, Cuddy P, Baker B. The effects of sucralfate suspension on radiotherapy induced mucositis. Oral Surg Oral Med Oral Pathol 1991; 71: 288–293
  • Franzen L, Henriksson R, Littbrand B, Zackrisson B. Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebocontrolled study.Acta Oncol 1995; 34: 219-223
  • Spijkervet FKL, Saene HKF van, Panders AK et al. Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis. Oral Surg Oral Med Oral Pathol 1989; 67: 154- 161.
  • Epstein JB, Stevenson-Moore P. Benzydamine hydrochloride in prevention and management of pain in oral mucositis associated with radiation therapy. Int J Radiat Oncol Bio Phys 1986; 62: 145–148
  • Wadleigh RG, Redman RS, Graham ML. Vitamin E in the treatment of chemotherapy-induced mucositis. Am J.Med 1992; 92: 481-484.
  • Ciasis G, Namer M, Schneider M. Laser therapy in the prevention and treatment of mucositis caused by anticancer chemotherapy. Bull Cancer Paris 1992; 79: 183–191
  • Joseph A. Regezi, James J. Scubba, Richard C.K. Jordan. Oral Pathology. Saunders. USA 2003:7679
  • Thomas CJ, Nutt GM. The in vitro fungicidal properties of Viscogel alone and combined with Nystatin and Amphotericin B. Oral Rehab 1978; 5:167–172
  • Meunier F, Paesmans M, Autier P. Value of antifungal prophylaxis with antifungal drugs againist oropharyngeal candidiasis in cancer patients. Oral Oncol,Eur J Cancer 30B,196-199
  • Barkvoll P, Attramadal A. Effect of nystatin and chlorhexidine digluconate on Candida albicans. Oral Surg Oral Med Oral Pathol 1989;67:279-281
  • Stephen LC, Schulthesiss TE, Price RE, Ang KK, Peters LI. Radiation apoptosis of serous acinar cells of salivary and lacrimal glands.Cancer 1991; 67: 1539-1543
  • Mira JG, Fullerton GD, Wescott WB. Correlation between initial salivary flow rate and radiation dose in the production of xerostomia.Acta Radiol Oncol 1982; 21: 151-154
  • Shum CA, Izutsu KT, Molbo DM et al. Changes in salivary buffer capacity in patients undergoing cancer chemotherapy.J Oral Med 1979; 34: 76-80
  • Robert A.O, Blanchaert R. Current management of oral cancer: A multidisciplinary approach. JADA 2001; 32:19 -23
  • Herod EL. The use of milk as a saliva substitute. J Public Health Dent 1994;54:184-189
  • Risheim H, Amegerg P. Salivary stimulation by chewing gum and lozenges in rheumatic patients with xerostomia.Scand J Dent Res 1993;101:4043
  • Fox PC, Atkinson JC, Macynski AA et al. Pilocarpine treatment of salivary gland hypofunction and dry mouth(xerostomia). Arch Intern Med 1991;151: 1149–1152
  • Epstein JB, Burchill JL, Emerton S, Le N,Silverman S Jr. A clinical trial of bethanechol in patients with xerostomia after radiation therapy a pilot study. Oral Surg Oral Med Oral Pathol 1994; 77: 610– 614
  • Epstein J, Stevenson-Moore P.A. Clinical comparative trial of saliva substitutes in radiationinduced salivary gland hypofunction.Spec Care Dent 1992;12: 21-23
  • Visch LL, S’Gravenmade EJ; Schraub RM et al. A double blind crossover trial of CMC- and mucincontaining saliva substitutes. Int J Oral Maxillofac Surg 1986; 15: 395–400
  • Epstein JB, Schubert MM. Management of orofacial pain in cancer patients.Oral Oncol,Eur J Cancer 1993; 29B: 243-250
  • Berger A, Henderson M, Nadoolman W et al. Oral capsaicin provides temporary relief for oral mucositic pain secondary to chemotherapy/ radiation therapy. J Pain Symptom Manag 1995;10: 243–248
  • Mossman KL, Henkin RI Radiation-induced changes in taste acuity in cancer patients. Int J Radiat Oncol Phys 1978; 4: 663–670
  • Brunello DL, Mandikos MN. The use of a dynamic opening device in the treatment of radiation induced trismus.Aust Prosthodont J 1995; 9: 4548
  • Lockhart PB, Clark J. Pretherapy dental status of patients with malignant conditions of the head and neck. Oral Surg 1994; 77: 236–241
  • Feber T. Mouth care for patients receiving oral irradiation. Professional Nurse 1995;10: 666–670
  • Scully C, Flint S, Porter SR. Oral diseases. London: Martin Dunitz, 1996; 198.
  • Kluth EV, Jain PR, Struhell RN, Frich JC. A study of factors contributing to development of osteoradionecrosis of the jaws. J Prosth Dent 1988; 59: 194–201
  • McKenize MR, Wong FLW, Epstein JB, Lepawsky M. Hyperbaric oxygen and postradiation osteonecrosis of the mandible. Oral Oncol,Eur J Cancer 1993; 29B: 201-207
  • King GE, Scheetz J,Jacob RF et al. Electrotherapy and hyperbaric oxygen:promising treatments for post-radiation complications. J Prosthet Dent 1989; 62: 331–334
  • Harris M. The conservative management of osteoradionecrosis of the mandible with ultrasound therapy. Br J Oral Maxillofac Surg 1992; 30: 313–318
  • Reher P, Doan N, Bradnock B, Meghji S, Haris M. Therapeutic ultrasound for osteoradionecrosis: an in vitro comparison between 1 MHz and 45 kHz machines. Eur J Cancer 1998; 34: 1962–1968
Toplam 38 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Yazarlar

Yrd. Doç. Dr. Binali Çakur Bu kişi benim

Araş. Gör. Dt. Özkan Miloğlu Bu kişi benim

Prof. Dr. Abubekir Harorlı Bu kişi benim

Yayımlanma Tarihi 1 Mart 2006
IZ https://izlik.org/JA82YY65MG
Yayımlandığı Sayı Yıl 2006 Cilt: 2006 Sayı: 3

Kaynak Göster

APA Çakur, Y. D. D. B., Miloğlu, A. G. D. Ö., & Harorlı, P. D. A. (2006). RADYOTERAPİ VE KEMOTERAPİ GÖREN HASTALARDA ORAL BAKIM. Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi, 2006(3), 50-55. https://izlik.org/JA82YY65MG
AMA 1.Çakur YDDB, Miloğlu AGDÖ, Harorlı PDA. RADYOTERAPİ VE KEMOTERAPİ GÖREN HASTALARDA ORAL BAKIM. Ata Diş Hek Fak Derg. 2006;2006(3):50-55. https://izlik.org/JA82YY65MG
Chicago Çakur, Yrd. Doç. Dr. Binali, Araş. Gör. Dt. Özkan Miloğlu, ve Prof. Dr. Abubekir Harorlı. 2006. “RADYOTERAPİ VE KEMOTERAPİ GÖREN HASTALARDA ORAL BAKIM”. Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi 2006 (3): 50-55. https://izlik.org/JA82YY65MG.
EndNote Çakur YDDB, Miloğlu AGDÖ, Harorlı PDA (01 Mart 2006) RADYOTERAPİ VE KEMOTERAPİ GÖREN HASTALARDA ORAL BAKIM. Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi 2006 3 50–55.
IEEE [1]Y. D. D. B. Çakur, A. G. D. Ö. Miloğlu, ve P. D. A. Harorlı, “RADYOTERAPİ VE KEMOTERAPİ GÖREN HASTALARDA ORAL BAKIM”, Ata Diş Hek Fak Derg, c. 2006, sy 3, ss. 50–55, Mar. 2006, [çevrimiçi]. Erişim adresi: https://izlik.org/JA82YY65MG
ISNAD Çakur, Yrd. Doç. Dr. Binali - Miloğlu, Araş. Gör. Dt. Özkan - Harorlı, Prof. Dr. Abubekir. “RADYOTERAPİ VE KEMOTERAPİ GÖREN HASTALARDA ORAL BAKIM”. Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi 2006/3 (01 Mart 2006): 50-55. https://izlik.org/JA82YY65MG.
JAMA 1.Çakur YDDB, Miloğlu AGDÖ, Harorlı PDA. RADYOTERAPİ VE KEMOTERAPİ GÖREN HASTALARDA ORAL BAKIM. Ata Diş Hek Fak Derg. 2006;2006:50–55.
MLA Çakur, Yrd. Doç. Dr. Binali, vd. “RADYOTERAPİ VE KEMOTERAPİ GÖREN HASTALARDA ORAL BAKIM”. Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi, c. 2006, sy 3, Mart 2006, ss. 50-55, https://izlik.org/JA82YY65MG.
Vancouver 1.Yrd. Doç. Dr. Binali Çakur, Araş. Gör. Dt. Özkan Miloğlu, Prof. Dr. Abubekir Harorlı. RADYOTERAPİ VE KEMOTERAPİ GÖREN HASTALARDA ORAL BAKIM. Ata Diş Hek Fak Derg [Internet]. 01 Mart 2006;2006(3):50-5. Erişim adresi: https://izlik.org/JA82YY65MG

Bu eser Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır. Tıklayınız.